Natural History of Perianal Crohn's Disease After Fecal Diversion
暂无分享,去创建一个
A. Ananthakrishnan | J. Korzenik | J. Sauk | H. Khalili | D. Nguyen | R. Hodin | P. Shellito | S. Friedman | V. Yajnik | P. Sylla | G. Konijeti | L. Bordeianou
[1] Y. Panis,et al. Case Series: Does a Combination of Anti-TNF Antibodies and Transient Ileal Fecal Stream Diversion in Severe Crohn's Colitis With Perianal Fistula Prevent Definitive Stoma? , 2013, The American Journal of Gastroenterology.
[2] A. Ananthakrishnan,et al. Impact of Coexistent Celiac Disease on Phenotype and Natural History of Inflammatory Bowel Diseases , 2013, The American Journal of Gastroenterology.
[3] Amit P. Desai,et al. Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.
[4] W. Sandborn,et al. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change , 2011, Gut.
[5] G. Savoye,et al. Fistulizing perianal Crohn's disease: Contrast‐enhanced magnetic resonance imaging assessment at 1 year on maintenance anti‐TNF‐alpha therapy , 2011, Inflammatory bowel diseases.
[6] S. Bell,et al. Faecal diversion in the management of perianal Crohn’s disease , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[7] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[8] M. Kreis,et al. Long-Term Quality of Life in Patients with Crohn’s Disease and Perianal Fistulas: Influence of Fecal Diversion , 2007, Diseases of the colon and rectum.
[9] M. Kreis,et al. Risk of Fecal Diversion in Complicated Perianal Crohn’s Disease , 2007, Journal of Gastrointestinal Surgery.
[10] A. Stromberg,et al. Perianal Crohn Disease: Predictors of Need for Permanent Diversion , 2005, Annals of surgery.
[11] P. Rutgeerts,et al. Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.
[12] P. Rutgeerts,et al. Management of perianal Crohn's disease. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[13] P. Rutgeerts,et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.
[14] P. Rutgeerts,et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.
[15] W. Cooke,et al. The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel , 1971, Gut.
[16] K. Taylor,et al. Diverting ileostomy in the surgical management of Crohn's disease of the colon. , 1968, American journal of surgery.
[17] J. Stockman. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2009 .
[18] I. Kodner,et al. Techniques and results in the management of anal and perianal Crohn's disease. , 1989, Surgery, gynecology & obstetrics.